Evidence map›Paper›PMID 31668295›Full record

ReviewSeminars in pediatric surgery2019

Clinical management in mixed gonadal dysgenesis with chromosomal mosaicism: Considerations in newborns and adolescents.

Erica M Weidler, Margaret Pearson, Kathleen van Leeuwen, Erin Garvey

Abstract readReview
In one paragraph

Review in Seminars in pediatric surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. <italic>WT1</italic> Deletion in 46,XY DSD: The Importance of Copy Number Variant Analysis.Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Erica M WeidlerDivision of Pediatric Surgery, Phoenix Children's Hospital, MEd, 1919 E. Thomas Rd., Phoenix, AZ 85016, United States. Electronic address: ebaimbridge@phoenixchildrens.com.
Margaret PearsonDepartment of Genetics, District Medical Group, Phoenix, AZ, United States.
Kathleen van LeeuwenDivision of Pediatric Surgery, Phoenix Children's Hospital, MEd, 1919 E. Thomas Rd., Phoenix, AZ 85016, United States.
Erin GarveyDivision of Pediatric Surgery, Phoenix Children's Hospital, MEd, 1919 E. Thomas Rd., Phoenix, AZ 85016, United States.
Phoenix Children's Hospital · USPhoenix (United States) · US

Funding

Disorders/Differences of Sex Development (DSD) - Translational Research NetworkR01HD093450 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SANDBERG, DAVID ERIC, VILAIN, ERIC J. · 2018 to 2022
$3.9M
NICHD NIH HHS R01 HD093450
6 · The paper itself

Abstract

Individuals born on the spectrum of genetic abnormalities known as mixed gonadal dysgenesis (MGD) have a wide range of anatomical findings and management can be challenging in the newborn and adolescent. Historically, many individuals with MGD have undergone gonadectomy to avert the risk of gonadal malignancy. However, gonadectomy deprives patients of the benefits of their endogenous hormones, potential fertility, and in the case with MGD, has historically been done prior to addressing gender identity. Some patient advocates have proposed a delayed approach to surgical reconstructions and/or gonadectomy in other differences/disorders of sex development (DSD), particularly in patients with congenital adrenal hyperplasia and androgen insensitivity syndrome. In many areas of the world, there continues to be a shift toward delayed reconstructions and hesitancy regarding irreversible gonadectomy. To date, no clinical management protocol addressing these issues from a patient-centered approach has been described. We review what is known about malignancy risk and propose a management protocol for those with MGD that involves shared decision making regarding the gonads and addresses the long-term challenges with regard to gender and anatomy.

Indexed as

MosaicismAdolescentBiopsyDecision Making, SharedEthics, MedicalFertilityGender IdentityGenetic Predisposition to DiseaseGonadal Dysgenesis, MixedHormone Replacement TherapyHumansImmunohistochemistryInfant, NewbornKaryotypingLaparoscopyMagnetic Resonance ImagingChromosomal abnormalityGonadectomyGonadsMalignancy riskMixed gonadal dysgenesisMosaicism

Identifiers

PMID31668295
PMCPMC6922540
OpenAlexW2974612615

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.